GlassScriptPhysician profile
Ian S Bach
NPI 1003895293
$1,159.78
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,011 · 2020: $135 · 2021: $13.34.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $142.65 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $123.49 | 2019 | |
| Novartis Pharmaceuticals Corporation | $117.24 | 2019-2020 | |
| Amgen INC. | $111.16 | 2019 | |
| Novo Nordisk INC | $99.24 | 2019 | |
| Pfizer INC. | $83.06 | 2019-2020 | |
| Astellas Pharma US INC | $79.35 | 2019-2020 | |
| Glaxosmithkline, LLC. | $78.84 | 2019 | |
| Lilly USA, LLC | $49.44 | 2019 | |
| Janssen Pharmaceuticals, INC | $46.95 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $36.95 | 2019 | |
| Merck Sharp & Dohme LLC | $25.44 | 2019 | |
| Ucb, INC. | $21.80 | 2019 | |
| Medtronic Minimed, INC. | $20.86 | 2019 | |
| Shire North American Group INC | $19.61 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $18.87 | 2020 | |
| Philips North America LLC | $17.97 | 2019 | |
| Aytu Biopharma, INC. | $15.89 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $13.68 | 2019 | |
| Medtronic, INC. | $13.34 | 2021 | |
| Cranial Technologies, INC | $12.29 | 2020 | |
| Allergan, INC. | $11.66 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ian Bach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.